$54.14 1%
BMY Stock Price vs. AI Score
Data gathered: November 9

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Bristol-Myers Squibb

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.


Bristol-Myers Squibb
Price $54.14
Target Price Sign up
Volume 9,220,000
Market Cap $110B
Year Range $39.03 - $55.95
Dividend Yield 4.39%
PE Ratio 12.66
Analyst Rating 20% buy
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2411.9B7.5B4.39B1.21B-129M1.800
Q2 '2412.2B7.67B4.53B1.68B-438M2.070
Q1 '2411.9B7.77B4.09B-11.9B-8.69B-4.400
Q4 '2311.5B7.19B4.29B1.76B4.29B1.590
Q3 '2311B6.93B4.03B1.93B4.71B2.000

Insider Transactions View All

Holzer Phil M filed to sell 11,760 shares at $55.6.
November 5 '24
Hirawat Samit filed to buy 62,109 shares at $54.7.
November 5 '24
BOERNER CHRISTOPHER S. filed to buy 82,672 shares at $49.8.
December 7 '23
BOERNER CHRISTOPHER S. filed to buy 79,384 shares at $48.9.
November 30 '23
Samuels Theodore R. II filed to buy 35,500 shares at $49.8.
November 21 '23

Congress Trading View All

Politician Filing Date Type Size
John James
Sep 2, 24 Buy $1K - $15K
Rohit Khanna
Democrat
Jun 5, 24 Sell $15K - $50K
Rohit Khanna
Democrat
Jun 5, 24 Sell $15K - $50K

What is the Market Cap of Bristol-Myers Squibb?

The Market Cap of Bristol-Myers Squibb is $110B.

What is Bristol-Myers Squibb's PE Ratio?

As of today, Bristol-Myers Squibb's PE (Price to Earnings) ratio is 12.66.

What is the current stock price of Bristol-Myers Squibb?

Currently, the price of one share of Bristol-Myers Squibb stock is $54.14.

How can I analyze the BMY stock price chart for investment decisions?

The BMY stock price chart above provides a comprehensive visual representation of Bristol-Myers Squibb's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bristol-Myers Squibb shares. Our platform offers an up-to-date BMY stock price chart, along with technical data analysis and alternative data insights.

Does BMY offer dividends to its shareholders?

Yes, Bristol-Myers Squibb (BMY) offers dividends to its shareholders, with a dividend yield of 4.39%. This dividend yield represents Bristol-Myers Squibb's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bristol-Myers Squibb in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Bristol-Myers Squibb?

Some of the similar stocks of Bristol-Myers Squibb are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.